Search results
Results from the WOW.Com Content Network
Osteopenia, known as "low bone mass" or "low bone density", is a condition in which bone mineral density is low. [1] Because their bones are weaker, people with osteopenia may have a higher risk of fractures, and some people may go on to develop osteoporosis. [2]
The International Osteoporosis Foundation and the European Calcified Tissue Society recommend pharmacological therapy for osteoporosis in postmenopausal women and men ≥70 years, with a previous fragility fracture, or a dose equivalent of prednisone ≥7.5 mg daily for ≥3 months. For premenopausal women and men <50 years taking steroids for ...
“Muscle is the fountain of youth because it is vital to your metabolic health, your strength, and prevents aging disorders, such as [type 2 diabetes], heart disease, stroke, osteopenia, memory ...
A higher rate of resorption is often caused by increased osteoclastogenesis and results in symptoms of osteopenia such as excessive bone loss and low bone mineral density. [39] Osteoporosis is often triggered in post-menopausal women due to reduced estrogen levels associated with the depletion of hormone-releasing ovarian follicles. [40]
The treatment left her in agony, in bed for six weeks. ... Bone-building drug coming for post-menopause women. ... Under the new fracture protocols he got a DXA bone scan showing he has osteopenia
It affects women more than men due to the sharp fall in estrogen production that follows menopause. [193] Globally, it is estimated that 21.2% of women and 6.3% of men over the age of 50 have osteoporosis, corresponding to a total of around 500 million people worldwide. [194] About 15% of Caucasians in their 50s and 70% of those over 80 are ...
This treatment uses synthetic testosterone to increase circulating testosterone levels and reduce low T symptoms. TRT comes in several forms, including skin patches, topical gels, oral capsules ...
The Women's Health Initiative (WHI) is an ongoing study of over 27,000 women that began in 1991, with the most recent analyses suggesting that, when initiated within 10 years of menopause, HRT reduces all-cause mortality and risks of coronary disease, osteoporosis, and dementia; after 10 years the beneficial effects on mortality and coronary ...